VSV-EBOVAC: Vaccine Safety and Immunogenicity Signatures of Human Responses to VSV-ZEBOV

Source: Innovative Medicines Initiative (IMI). Published: 2/2019. This web page provides information about the development of a new vaccine, VSV-ZEBOV, which has proven to be highly effective against the Ebola virus. Partners in the project VSV-EBOVAC analyzed the data and samples from early-phase clinical trials of the vaccine to find out more about what happens to the body after immunization, and how, exactly, it confers protection. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news